Sleep Restriction and Obesity
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators hypothesize that sleep restriction will result in increased energy balance.
| Condition | Intervention |
|---|---|
|
Obesity |
Behavioral: Sleep restriction |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Sleep Restriction and Obesity |
- Change in caloric intake [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]
- Change in activity energy expenditure [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]Change in activity energy expenditure, measured during acclimation, experimental, and recovery.
- Change in total energy expenditure [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]Change in total energy expenditure, a combination of activity energy expenditure, thermic effect of food (TEF), and basal metabolic rate (BMR).
- Change in leptin levels, fat tissue characteristics, and body composition [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]Changes in energy expenditure will be associated with alterations in fat tissue characteristics from serial fat biopsies, and altered body composition measured by DEXA and computed tomography imaging
- Change in neurocognitive deficits [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]Change in neurocognitive function measured by battery.
- Change in blood pressure and autonomic function [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]Change in mean arterial blood pressure and autonomic function over 24 hour periods.
- Change in markers of inflammation and endothelial function [ Time Frame: baseline to 21 days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 20 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | June 2018 |
| Estimated Primary Completion Date: | June 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Sleep restriction
Sleep restriction
|
Behavioral: Sleep restriction
14 days of sleep restriction, 4 hours of sleep per day.
|
|
No Intervention: Normal sleep
Normal sleep
|
Detailed Description:
Numerous studies have reported that self-reported short sleep duration is associated with obesity and weight gain. Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. Given that sleep restriction is largely voluntary and potentially correctable, understanding the mechanisms that link insufficient sleep to positive energy balance and the development of obesity, particularly visceral obesity, is crucial to clinical applications, public health policy, and informing future studies. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators will combine energy balance, biomarker, and imaging data with state-of-the art sleep monitoring to provide unambiguous data on the effects of sleep restriction on obesity. Together, the investigators findings will help explain whether the reduced sleep duration in the general population may be contributing to the current epidemic of obesity, and suggest strategies to reduce this risk.
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18-40 years
- BMI of 18.5-24.9 kg/m2
- Not a current smoker or tobacco user
- No chronic medical or psychiatric disorders
- On no prescription medications other than second generation antihistamines (cetirizine, fexofenadine, desloratadine, loratadine, etc), oral contraceptive pills, or intrauterine devices
- History of normal sleep patterns, defined as nocturnal sleep duration of 6.5-8 hours per night without regular daytime naps
Exclusion Criteria:
- The investigators will exclude subjects who have any medical or psychiatric disorders
- History of anxiety or depression
- Those taking any medications other than non-sedating antihistamines or oral contraceptives will be excluded
- Those found to have depression on a depression screening tool (BDI-II) will be excluded
- Current smokers will be excluded
- All female subjects will undergoing a screening pregnancy test and excluded if positive
- Subjects found to have significant sleep disorders will be excluded
Contacts and Locations| Contact: Diane E Davison, MA, RN | 507-255-8794 | davison.diane@mayo.edu |
| United States, Minnesota | |
| Mayo Clinic in Rochester | Recruiting |
| Rochester, Minnesota, United States, 55905 | |
| Principal Investigator: | Virend Somers, MD, PhD | Mayo Clinic |
More Information
No publications provided
| Responsible Party: | Virend Somers, MD, PhD, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT01580761 History of Changes |
| Other Study ID Numbers: | 11-007272 |
| Study First Received: | April 17, 2012 |
| Last Updated: | February 25, 2013 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Obesity Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013